Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Singapore for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage Hormone Receptor Positive HER2-Positive Breast Cancer

… approval of NERLYNX® (neratinib) in Singapore from the Health Sciences Authority … board under the Ministry of Health of the Singapore Government. NERLYNX is indicated … [email protected] KEYWORD: SINGAPORE UNITED STATES NORTH AMERICA ASIA …